Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metformin improves vascular function in insulin-resistant rats.

P V Katakam1, M R Ujhelyi, M Hoenig

  • 1University of Georgia Colleges of Pharmacy, Augusta VA Medical Center, Augusta, GA, USA.

Hypertension (Dallas, Tex. : 1979)
|January 21, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Updated EBMT/ESID inborn errors working party guidelines for haematopoietic stem cell transplantation for inborn errors of immunity and metabolism.

Bone marrow transplantation·2026
Same author

Conditioning Regimens for Hematopoietic Cell Transplantation in Primary Immunodeficiency.

Current allergy and asthma reports·2019
Same author

Effects of the sodium-glucose cotransporter 2 (SGLT2) inhibitor velagliflozin, a new drug with therapeutic potential to treat diabetes in cats.

Journal of veterinary pharmacology and therapeutics·2017
Same author

The Cause of Acute Respiratory Failure Predicts the Outcome of Noninvasive Ventilation in Immunocompromised Children.

Klinische Padiatrie·2015
Same author

Successful HLA haploidentical hematopoietic SCT in chronic granulomatous disease.

Bone marrow transplantation·2014
Same author

Effects of pioglitazone on insulin sensitivity and serum lipids in obese cats.

Journal of veterinary internal medicine·2014

Metformin improves vascular function in insulin-resistant rats by directly enhancing nitric oxide-dependent relaxation, not by improving metabolic issues. This effect was observed both in vivo and in vitro.

Area of Science:

  • Pharmacology
  • Cardiovascular Physiology
  • Endocrinology

Background:

  • Insulin resistance (IR) is associated with impaired endothelial function and cardiovascular complications.
  • Metformin is a primary treatment for type 2 diabetes, known for improving insulin sensitivity.
  • The direct vascular effects of metformin, independent of its metabolic actions, require further elucidation.

Purpose of the Study:

  • To assess the impact of metformin on mean arterial pressure (MAP), insulin levels, and endothelial function in insulin-resistant rats.
  • To investigate the direct in vitro effects of metformin on vascular function in isolated arteries.
  • To determine whether metformin's vascular benefits are mediated by metabolic improvements or direct mechanisms.

Main Methods:

  • Sprague-Dawley rats were induced into insulin resistance and randomized to receive metformin or placebo for two weeks.

Related Experiment Videos

  • Endothelial function was assessed in isolated mesenteric arteries using acetylcholine (ACh) dose-response curves, with and without N-nitro-L-arginine (LNNA).
  • In vitro experiments involved direct metformin treatment of arteries before ACh stimulation.

    • Main Results:

    • Metformin treatment improved MAP and insulin levels in insulin-resistant rats compared to placebo.
    • Maximal relaxation to ACh was significantly enhanced in metformin-treated IR rats, approaching control levels.
    • Both in vivo and in vitro metformin improved acetylcholine-induced relaxation, indicating a direct, nitric oxide-dependent mechanism.

    Conclusions:

    • Metformin directly improves endothelial function in insulin-resistant rats, independent of its effects on metabolic abnormalities.
    • The vascular benefits of metformin appear to be mediated through a nitric oxide-dependent pathway.
    • These findings suggest a direct therapeutic role for metformin in managing vascular dysfunction associated with insulin resistance.